Q4 2024 Holdings
Filed 2025-02-14 | 95 holdings | $9.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Surrozen, Inc.(SRZNW) | W EXP 8/11/2026 | 86889P117 | $17.8K | 833,333 | 0.0% |
| Tyra Biosciences, Inc.(TYRA) | COM | 90240B106 | $147.4K | 10,607 | 0.0% |
| Foghorn Therapeutics Inc.(FHTX) | COM | 344174107 | $212.5K | 45,027 | 0.0% |
| Acrivon Therapeutics, Inc.(ACRV) | COMMON STOCK | 004890109 | $318.4K | 52,885 | 0.0% |
| PMV Pharmaceuticals, Inc.(PMVP) | COM | 69353Y103 | $486.3K | 322,024 | 0.0% |
| Century Therapeutics, Inc.(IPSC) | COM | 15673T100 | $805.4K | 797,460 | 0.0% |
| PTC Therapeutics, Inc.(PTCT) | COM | 69366J200 | $920.9K | 20,400 | 0.0% |
| Rocket Pharmaceuticals, Inc.(RCKT) | COM | 77313F106 | $1.2M | 97,079 | 0.0% |
| vTv Therapeutics, Inc.(VTVT) | CL A | 918385204 | $1.3M | 97,314 | 0.0% |
| Mersana Therapeutics, Inc. | COM | 59045L106 | $1.6M | 1,086,115 | 0.0% |
| Hookipa Pharma Inc.(HOOK) | COM | 43906K209 | $1.6M | 812,814 | 0.0% |
| Generation Bio Co.(GBIOGBX) | COM | 37148K100 | $2.1M | 1,944,945 | 0.0% |
| Compass Therapeutics, Inc.(CMPX) | COM | 20454B104 | $2.3M | 1,557,630 | 0.0% |
| Arcturus Therapeutics Holdings Inc.(ARCT) | COM | 03969T109 | $2.6M | 151,329 | 0.0% |
| Enliven Therapeutics, Inc.(ELVN) | COM | 29337E102 | $2.6M | 114,833 | 0.0% |
| Protara Therapeutics, Inc.(TARA) | COM STK | 74365U107 | $2.8M | 536,832 | 0.0% |
| Prime Medicine, Inc.(PRME) | COM | 74168J101 | $3.0M | 1,028,466 | 0.0% |
| Aligos Therapeutics, Inc.(ALGS) | COM | 01626L204 | $3.3M | 83,055 | 0.0% |
| Leap Therapeutics, Inc.(CYPH) | COM | 52187K200 | $3.4M | 1,172,175 | 0.0% |
| Sana Biotechnology, Inc.(SANA) | COM | 799566104 | $3.9M | 2,380,949 | 0.0% |
| Vaxcyte, Inc.(PCVX) | COM | 92243G108 | $4.0M | 48,885 | 0.0% |
| Skye Bioscience, Inc.(SKYE) | COM | 83086J200 | $4.1M | 1,450,638 | 0.0% |
| Wave Life Sciences Ltd.(WVE) | SHS | Y95308105 | $4.3M | 344,063 | 0.0% |
| Sagimet Biosciences Inc.(SGMT) | COM SER A | 786700104 | $4.3M | 952,996 | 0.0% |
| DBV Technologies S.A.(DBVT) | SPONSORED ADS | 23306J309 | $4.5M | 1,461,425 | 0.0% |
| Contineum Therapeutics, Inc.(CTNM) | CL A | 21217B100 | $4.6M | 312,500 | 0.0% |
| Relay Therapeutics, Inc.(RLAY) | COM | 75943R102 | $4.8M | 1,160,117 | 0.1% |
| Disc Medicine, Inc.(IRON) | COM | 254604101 | $4.9M | 77,050 | 0.1% |
| BioNTech SE(BNTX) | SPONSORED ADS | 09075V102 | $5.1M | 45,031 | 0.1% |
| Fate Therapeutics, Inc.(FATE) | COM | 31189P102 | $5.4M | 3,258,402 | 0.1% |
| Biomea Fusion, Inc.(BMEA) | COM | 09077A106 | $5.6M | 1,451,990 | 0.1% |
| Celldex Therapeutics, Inc.(CLDX) | COM | 15117B202 | $6.3M | 247,644 | 0.1% |
| Taysha Gene Therapies, Inc.(TSHA) | COM SHS | 877619106 | $6.9M | 4,004,756 | 0.1% |
| 2seventy bio, Inc.(TSVT*) | COMMON STOCK | 901384107 | $7.3M | 2,497,526 | 0.1% |
| Intellia Therapeutics, Inc.(NTLA) | COM | 45826J105 | $7.5M | 644,116 | 0.1% |
| Arvinas, Inc.(ARVN) | COM | 04335A105 | $7.8M | 405,576 | 0.1% |
| Mirum Pharmaceuticals, Inc.(MIRM) | COM | 604749101 | $7.9M | 190,476 | 0.1% |
| Vir Biotechnology, Inc.(VIR) | COM | 92764N102 | $8.0M | 1,084,539 | 0.1% |
| Kala BIO, Inc.(KALA) | COM | 483119202 | $8.3M | 1,201,894 | 0.1% |
| TScan Therapeutics, Inc.(TCRX) | COM | 89854M101 | $8.5M | 2,784,792 | 0.1% |
| Opthea Limited | SPONSORED ADS | 68386J208 | $8.5M | 2,173,622 | 0.1% |
| Verve Therapeutics, Inc. | COM | 92539P101 | $9.5M | 1,691,530 | 0.1% |
| Structure Therapeutics Inc.(GPCR) | SPONSORED ADS | 86366E106 | $9.8M | 361,565 | 0.1% |
| Design Therapeutics, Inc.(DSGN) | COM | 25056L103 | $10.8M | 1,743,725 | 0.1% |
| Neumora Therapeutics, Inc.(NMRA) | COM | 640979100 | $11.0M | 1,034,600 | 0.1% |
| Alumis Inc.(ALMS) | COM | 022307102 | $12.3M | 1,562,500 | 0.1% |
| Ionis Pharmaceuticals, Inc.(IONS) | COM | 462222100 | $12.5M | 357,915 | 0.1% |
| Prelude Therapeutics Inc.(PRLD) | COM | 74065P101 | $12.9M | 10,123,824 | 0.1% |
| Bicara Therapeutics Inc.(BCAX) | COM | 055477103 | $14.5M | 833,333 | 0.2% |
| Xencor, Inc.(XNCR) | COM | 98401F105 | $15.4M | 670,431 | 0.2% |